Walgreens enters clinical trials business through new unit – Reuters

Walgreens enters clinical trials business through new unit – Reuters

A person is seen shopping in Walgreens, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021. REUTERS/Andrew Kelly
June 16 (Reuters) – Walgreens Boots Alliance Inc (WBA.O) on Thursday launched a clinical trials business that aims to use patient data from its pharmacies to help drive up recruitment in studies conducted by drugmakers.
Best known for its chain of drugstores, Walgreens has been looking to expand beyond its core business and spent $5.5 billion last year to take majority stakes in two health care providers, VillageMD and CareCentrix.
With the clinical trials business, the company plans to use its vast trove of data and new services to help cut costs for drugmakers and capture a share of the roughly $83 billion market.
"This is yet another way we are building our next growth engine of consumer-centric healthcare solutions," said Ramita Tandon, Walgreen’s chief clinical trials officer.
Our Standards: The Thomson Reuters Trust Principles.
Chile confirmed on Friday the country’s first case of monkeypox, the health ministry said in a statement.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world’s media organizations, industry events and directly to consumers.
Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology.
The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs.
The industry leader for online information for tax, accounting and finance professionals.
Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile.
Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts.
Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks.
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2022 Reuters. All rights reserved

source


Leave a Reply

Your email address will not be published.